Literature DB >> 814254

Liver dysfunction following small-bowel bypass for obesity. Nonoperative treatment of fatty metamorphosis with parenteral hyperalimentation.

F C Ames, E M Copeland, D C Leeb, D L Moore, S J Dudrick.   

Abstract

A patient with liver dysfunction following small-bowel bypass for obesity was treated successfully with intravenous hyperalimentation. The hepatic steatosis and dysfunction were most likely caused by the preferential absorption of carbohydrate in the remaining small bowel, with resulting relative protein starvation. Routine use of high-protein, low-carbohydrate diets postoperatively until weight stabilization has occurred may prevent this complication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814254

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Heroes and friends.

Authors:  E M Copeland
Journal:  Ann Surg       Date:  2000-05       Impact factor: 12.969

2.  Bypass induced liver disease: an experimental study of the effect of post-operative protein supplementation and metronidazole therapy in an animal model.

Authors:  M R Lewin; J G Araujo; J L Sarmiento; T P Barton; A P Jayaraj; R A Harrison
Journal:  Br J Exp Pathol       Date:  1987-02

Review 3.  Surgical management of morbid obesity.

Authors:  S N Joffe
Journal:  Gut       Date:  1981-03       Impact factor: 23.059

4.  Abnormal liver function during nutritional support in postoperative cancer patients.

Authors:  F D Skidmore; D E Tweedle; E N Gleave; E Gowland; D A Knass
Journal:  Ann R Coll Surg Engl       Date:  1979-05       Impact factor: 1.891

5.  The price of weight loss by jejunoileal shunt.

Authors:  M M Ravitch; R E Brolin
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

6.  Liver injury following jejunoileal bypass. Are there markers?

Authors:  S M Nasrallah; C E Wills; J T Galambos
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

Review 7.  A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease.

Authors:  P Riley; J O'Donohue; M Crook
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

8.  Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?

Authors:  Harjot K Gill; George Y Wu
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

9.  BSP clearance as the most reliable criterion of hepatic dysfunction after jejunoileal bypass in the rat: arguments in favor of the existence of a pathogenetic mechanism involving a transient malnutrition state.

Authors:  J F Grenier; J Marescaux; C Stock; G Coumaros; P Sava; F Michel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.